Click here to get full coverage on GH Research to Present Promising Results on GH001 at ACNP 2026 - TipRanks

GH Research to Present Promising Results on GH001 at ACNP 2026  TipRanks

GH Research to Present Promising Results on GH001 at ACNP 2026 - TipRanks

Click here to get full coverage on Is GHRS stock safe for conservative investors - Quarterly Trade Review & Growth Focused Entry Reports - newser.com

Is GHRS stock safe for conservative investors - Quarterly Trade Review & Growth Focused Entry Reports  newser.com

Is GHRS stock safe for conservative investors - Quarterly Trade Review & Growth Focused Entry Reports - newser.com

Click here to get full coverage on Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on HC Wainwright & Co. Maintains GH Research (GHRS) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains GH Research (GHRS) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains GH Research (GHRS) Buy Recommendation - Nasdaq

Click here to get full coverage on New Analyst Forecast: $GHRS Given $19.0 Price Target - Quiver Quantitative

New Analyst Forecast: $GHRS Given $19.0 Price Target  Quiver Quantitative

New Analyst Forecast: $GHRS Given $19.0 Price Target - Quiver Quantitative

Click here to get full coverage on GHRS: HC Wainwright Adjusts Price Target to $35, Maintains Buy R - GuruFocus

GHRS: HC Wainwright Adjusts Price Target to $35, Maintains Buy R  GuruFocus

GHRS: HC Wainwright Adjusts Price Target to $35, Maintains Buy R - GuruFocus

Click here to get full coverage on We're Not Very Worried About GH Research's (NASDAQ:GHRS) Cash Burn Rate - simplywall.st

We're Not Very Worried About GH Research's (NASDAQ:GHRS) Cash Burn Rate  simplywall.st

We're Not Very Worried About GH Research's (NASDAQ:GHRS) Cash Burn Rate - simplywall.st

Click here to get full coverage on Discipline and Rules-Based Execution in GHRS Response - news.stocktradersdaily.com

Discipline and Rules-Based Execution in GHRS Response  news.stocktradersdaily.com

Discipline and Rules-Based Execution in GHRS Response - news.stocktradersdaily.com

Click here to get full coverage on What recovery options are there for GHRS - Weekly Trade Report & Entry Point Confirmation Alerts - newser.com

What recovery options are there for GHRS - Weekly Trade Report & Entry Point Confirmation Alerts  newser.com

What recovery options are there for GHRS - Weekly Trade Report & Entry Point Confirmation Alerts - newser.com

Click here to get full coverage on GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial - Yahoo Finance

GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial  Yahoo Finance

GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial - Yahoo Finance

Click here to get full coverage on We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth - Yahoo Finance

We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth  Yahoo Finance

We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth - Yahoo Finance

Click here to get full coverage on Is GHRS stock bottoming out - 2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com

Is GHRS stock bottoming out - 2025 Institutional Moves & Fast Exit and Entry Strategy Plans  newser.com

Is GHRS stock bottoming out - 2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com

Click here to get full coverage on Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade - Yahoo Finance

Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade  Yahoo Finance

Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade - Yahoo Finance

Click here to get full coverage on What recovery options are there for GHRS - Portfolio Profit Report & Fast Moving Stock Watchlists - newser.com

What recovery options are there for GHRS - Portfolio Profit Report & Fast Moving Stock Watchlists  newser.com

What recovery options are there for GHRS - Portfolio Profit Report & Fast Moving Stock Watchlists - newser.com

Click here to get full coverage on Why GHRS stock attracts global investors - Quarterly Portfolio Summary & Intraday High Probability Alerts - newser.com

Why GHRS stock attracts global investors - Quarterly Portfolio Summary & Intraday High Probability Alerts  newser.com

Why GHRS stock attracts global investors - Quarterly Portfolio Summary & Intraday High Probability Alerts - newser.com

Click here to get full coverage on What valuation multiples suggest for GHRS stock - Quarterly Investment Review & Long-Term Safe Return Strategies - newser.com

What valuation multiples suggest for GHRS stock - Quarterly Investment Review & Long-Term Safe Return Strategies  newser.com

What valuation multiples suggest for GHRS stock - Quarterly Investment Review & Long-Term Safe Return Strategies - newser.com

Click here to get full coverage on Is GHRS stock bottoming out - Market Risk Analysis & Low Volatility Stock Suggestions - newser.com

Is GHRS stock bottoming out - Market Risk Analysis & Low Volatility Stock Suggestions  newser.com

Is GHRS stock bottoming out - Market Risk Analysis & Low Volatility Stock Suggestions - newser.com

Click here to get full coverage on Will GHRS stock deliver shareholder value - Quarterly Earnings Summary & Community Consensus Stock Picks - newser.com

Will GHRS stock deliver shareholder value - Quarterly Earnings Summary & Community Consensus Stock Picks  newser.com

Will GHRS stock deliver shareholder value - Quarterly Earnings Summary & Community Consensus Stock Picks - newser.com

Click here to get full coverage on Breakthrough Depression Drug Shows 73% Remission Rate Over 6 Months in Phase 2b Study - Stock Titan

Breakthrough Depression Drug Shows 73% Remission Rate Over 6 Months in Phase 2b Study  Stock Titan

Breakthrough Depression Drug Shows 73% Remission Rate Over 6 Months in Phase 2b Study - Stock Titan

Click here to get full coverage on Identifying reversal signals in GHRS - July 2025 Selloffs & AI Enhanced Trading Alerts - newser.com

Identifying reversal signals in GHRS - July 2025 Selloffs & AI Enhanced Trading Alerts  newser.com

Identifying reversal signals in GHRS - July 2025 Selloffs & AI Enhanced Trading Alerts - newser.com

Click here to get full coverage on RBC Capital Keeps Their Buy Rating on GH Research (GHRS) - The Globe and Mail

RBC Capital Keeps Their Buy Rating on GH Research (GHRS)  The Globe and Mail

RBC Capital Keeps Their Buy Rating on GH Research (GHRS) - The Globe and Mail

Click here to get full coverage on Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025 - Yahoo Finance

Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025  Yahoo Finance

Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025 - Yahoo Finance

Click here to get full coverage on Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation  Nasdaq

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Click here to get full coverage on Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga

Depression-Focused GH Research Shares Could See Significant Upside: Analyst  Benzinga

Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga

Click here to get full coverage on Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025 - Yahoo Finance

Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025  Yahoo Finance

Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025 - Yahoo Finance

Click here to get full coverage on GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat insider, and their holdings increased by 31% last week - Yahoo Finance

GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat insider, and their holdings increased by 31% last week  Yahoo Finance

GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat insider, and their holdings increased by 31% last week - Yahoo Finance

Click here to get full coverage on GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025  Yahoo Finance

GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

Click here to get full coverage on Here's Why We're Not Too Worried About GH Research's (NASDAQ:GHRS) Cash Burn Situation - Yahoo Finance

Here's Why We're Not Too Worried About GH Research's (NASDAQ:GHRS) Cash Burn Situation  Yahoo Finance

Here's Why We're Not Too Worried About GH Research's (NASDAQ:GHRS) Cash Burn Situation - Yahoo Finance

Click here to get full coverage on GH Research Announces Global Pivotal Program Plans and Further Development Updates - GlobeNewswire

GH Research Announces Global Pivotal Program Plans and Further Development Updates  GlobeNewswire

GH Research Announces Global Pivotal Program Plans and Further Development Updates - GlobeNewswire

Click here to get full coverage on GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates  Yahoo Finance

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance

Click here to get full coverage on GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance

GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates  Yahoo Finance

GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance

Click here to get full coverage on GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress | GHRS Stock News - Quiver Quantitative

GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress | GHRS Stock News  Quiver Quantitative

GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress | GHRS Stock News - Quiver Quantitative

Click here to get full coverage on GH Research reports progress on FDA engagement for GH001 IND - Investing.com

GH Research reports progress on FDA engagement for GH001 IND  Investing.com

GH Research reports progress on FDA engagement for GH001 IND - Investing.com

Click here to get full coverage on GH Research PLC Submits Complete Response to FDA's Clinical Hold on GH001 IND | GHRS Stock News - Quiver Quantitative

GH Research PLC Submits Complete Response to FDA's Clinical Hold on GH001 IND | GHRS Stock News  Quiver Quantitative

GH Research PLC Submits Complete Response to FDA's Clinical Hold on GH001 IND | GHRS Stock News - Quiver Quantitative

Click here to get full coverage on GH Research Unveils Pivotal Program Plans Amidst Promising Trial Results - TipRanks

GH Research Unveils Pivotal Program Plans Amidst Promising Trial Results  TipRanks

GH Research Unveils Pivotal Program Plans Amidst Promising Trial Results - TipRanks

Click here to get full coverage on GH Research Reports Q3 2025 Financial Results - TipRanks

GH Research Reports Q3 2025 Financial Results  TipRanks

GH Research Reports Q3 2025 Financial Results - TipRanks

Click here to get full coverage on H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛

H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40  富途牛牛

H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛

Click here to get full coverage on GH Research to Join TD Cowen Neuropsychiatry Summit - TipRanks

GH Research to Join TD Cowen Neuropsychiatry Summit  TipRanks

GH Research to Join TD Cowen Neuropsychiatry Summit - TipRanks

Click here to get full coverage on GH Research Presents Promising GH001 Trial Data at ECNP 2025 - TipRanks

GH Research Presents Promising GH001 Trial Data at ECNP 2025  TipRanks

GH Research Presents Promising GH001 Trial Data at ECNP 2025 - TipRanks

Click here to get full coverage on GH Research Responds to FDA Clinical Hold on Depression Treatment GH001 Ahead of Schedule - Yahoo Finance

GH Research Responds to FDA Clinical Hold on Depression Treatment GH001 Ahead of Schedule  Yahoo Finance

GH Research Responds to FDA Clinical Hold on Depression Treatment GH001 Ahead of Schedule - Yahoo Finance

Click here to get full coverage on GH Research’s GH001 Trial Results to be Presented at ACNP Meeting - TipRanks

GH Research’s GH001 Trial Results to be Presented at ACNP Meeting  TipRanks

GH Research’s GH001 Trial Results to be Presented at ACNP Meeting - TipRanks

Click here to get full coverage on GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule - GlobeNewswire

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule  GlobeNewswire

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule - GlobeNewswire

Click here to get full coverage on This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday  Benzinga

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Click here to get full coverage on CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $35 - 富途牛牛

CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $35  富途牛牛

CCORF Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $35 - 富途牛牛

Click here to get full coverage on GH Research to Engage at Stifel 2025 Healthcare Conference - TipRanks

GH Research to Engage at Stifel 2025 Healthcare Conference  TipRanks

GH Research to Engage at Stifel 2025 Healthcare Conference - TipRanks

Click here to get full coverage on GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress - GlobeNewswire

GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress  GlobeNewswire

GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress - GlobeNewswire

Click here to get full coverage on TD Cowen Maintains GH Research(GHRS.US) With Buy Rating - 富途牛牛

TD Cowen Maintains GH Research(GHRS.US) With Buy Rating  富途牛牛

TD Cowen Maintains GH Research(GHRS.US) With Buy Rating - 富途牛牛

Click here to get full coverage on GH Research PLC Provides Update on GH001 IND Response and Phase 2b Clinical Trial Results in Treatment-Resistant Depression - Quiver Quantitative

GH Research PLC Provides Update on GH001 IND Response and Phase 2b Clinical Trial Results in Treatment-Resistant Depression  Quiver Quantitative

GH Research PLC Provides Update on GH001 IND Response and Phase 2b Clinical Trial Results in Treatment-Resistant Depression - Quiver Quantitative

Click here to get full coverage on GH Research reports breakthrough in depression treatment - Investing.com

GH Research reports breakthrough in depression treatment  Investing.com

GH Research reports breakthrough in depression treatment - Investing.com

Click here to get full coverage on GH Research Announces Pricing of $150 Million Public Offering - GlobeNewswire

GH Research Announces Pricing of $150 Million Public Offering  GlobeNewswire

GH Research Announces Pricing of $150 Million Public Offering - GlobeNewswire

Click here to get full coverage on GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates  GlobeNewswire

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

Click here to get full coverage on GH Research Announces Proposed Public Offering - Yahoo Finance

GH Research Announces Proposed Public Offering  Yahoo Finance

GH Research Announces Proposed Public Offering - Yahoo Finance

Click here to get full coverage on GH Research Unveils Promising GH001 Trial Data at ECNP 2025 - TipRanks

GH Research Unveils Promising GH001 Trial Data at ECNP 2025  TipRanks

GH Research Unveils Promising GH001 Trial Data at ECNP 2025 - TipRanks

Click here to get full coverage on Anthropology Graduate Students Triumph at the GHRS - William & Mary

Anthropology Graduate Students Triumph at the GHRS  William & Mary

Anthropology Graduate Students Triumph at the GHRS - William & Mary

Click here to get full coverage on GH Research PLC Provides Business Updates and Financial Results, Advances Clinical Trials for GH001 in Treatment-Resistant Depression - Quiver Quantitative

GH Research PLC Provides Business Updates and Financial Results, Advances Clinical Trials for GH001 in Treatment-Resistant Depression  Quiver Quantitative

GH Research PLC Provides Business Updates and Financial Results, Advances Clinical Trials for GH001 in Treatment-Resistant Depression - Quiver Quantitative

Click here to get full coverage on Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect?  Yahoo Finance

Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Click here to get full coverage on Symposium to highlight graduate & honors research connections - W&M News

Symposium to highlight graduate & honors research connections  W&M News

Symposium to highlight graduate & honors research connections - W&M News

Click here to get full coverage on GH Research initiated with an Overweight at Cantor Fitzgerald - TipRanks

GH Research initiated with an Overweight at Cantor Fitzgerald  TipRanks

GH Research initiated with an Overweight at Cantor Fitzgerald - TipRanks

Click here to get full coverage on 3 Psychedelic Stocks to Ride to the Moon and Beyond - InvestorPlace

3 Psychedelic Stocks to Ride to the Moon and Beyond  InvestorPlace

3 Psychedelic Stocks to Ride to the Moon and Beyond - InvestorPlace

Click here to get full coverage on GHRS Stock Price and Chart — NASDAQ:GHRS - TradingView

GHRS Stock Price and Chart — NASDAQ:GHRS  TradingView

GHRS Stock Price and Chart — NASDAQ:GHRS - TradingView

Click here to get full coverage on GH Research (GHRS) - Zacks Investment Research

GH Research (GHRS)  Zacks Investment Research

GH Research (GHRS) - Zacks Investment Research

Click here to get full coverage on GH Research: But Toad Venom Is A Controlled Substance (NASDAQ:GHRS) - Seeking Alpha

GH Research: But Toad Venom Is A Controlled Substance (NASDAQ:GHRS)  Seeking Alpha

GH Research: But Toad Venom Is A Controlled Substance (NASDAQ:GHRS) - Seeking Alpha

Click here to get full coverage on GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - The Manila Times

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates  The Manila Times

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - The Manila Times

Click here to get full coverage on GHRS - Gh Research Plc Latest Stock News & Market Updates - Stock Titan

GHRS - Gh Research Plc Latest Stock News & Market Updates  Stock Titan

GHRS - Gh Research Plc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - GlobeNewswire

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer  GlobeNewswire

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - GlobeNewswire

Click here to get full coverage on GH Research: Can 'Toad Venom' Cure Depression? This Company Thinks It Can (NASDAQ:GHRS) - Seeking Alpha

GH Research: Can 'Toad Venom' Cure Depression? This Company Thinks It Can (NASDAQ:GHRS)  Seeking Alpha

GH Research: Can 'Toad Venom' Cure Depression? This Company Thinks It Can (NASDAQ:GHRS) - Seeking Alpha

Click here to get full coverage on GH Research PLC Announces Pricing of Initial Public Offering - PR Newswire

GH Research PLC Announces Pricing of Initial Public Offering  PR Newswire

GHRS

Price Chart

Key Statistics

Technicals

About GHRS

Latest News

GH Research to Present Promising Results on GH001 at ACNP 2026 - TipRanks

Is GHRS stock safe for conservative investors - Quarterly Trade Review & Growth Focused Entry Reports - newser.com

Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers